(E)-tert-butyl 4-(5-methoxy-5-oxopent-3-en-1-yl)piperidine-1-carboxylate

Catalog No. :
ACJEQM212
CAS No. :
2102414-88-8
Molecular Formula :
C16H27NO4
Molecular Weight :
297.39

IUPAC Name:tert-butyl (E)-4-(5-methoxy-5-oxopent-3-en-1-yl)piperidine-1-carboxylate

(E)-tert-butyl 4-(5-methoxy-5-oxopent-3-en-1-yl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$370.00Login to see priceInquiryInquiry
1g95%$925.00Login to see priceInquiryInquiry
5g95%$2776.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-tert-butyl 4-(5-methoxy-5-oxopent-3-en-1-yl)piperidine-1-carboxylate
IUPAC Nametert-butyl (E)-4-(5-methoxy-5-oxopent-3-en-1-yl)piperidine-1-carboxylate
Molecular FormulaC16H27NO4
Molecular Weight297.39
SMILESO=C(OC(C)(C)C)N1CCC(CC1)CC/C=C/C(OC)=O
InChI KeyGMRWKDNURRIYOZ-SOFGYWHQSA-N
Synonym(E)-tert-butyl 4-(5-methoxy-5-oxopent-3-en-1-yl)piperidine-1-carboxylate(WXC07150);(E)-tert-butyl 4-(5-methoxy-5-oxopent-3-en-1-yl)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-(5-methoxy-5-oxo-3-penten-1-yl)-, 1,1-dimethylethyl ester
CAS No.2102414-88-8

Synthetic Route by SureRoute

1. ACJEQM212 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDSFN864 route compound structure diagram
    ACDSFN864165528-85-8 In Stock
  2. Plus
  3. ACFUIK307 route compound structure diagram
    ACFUIK3071067-74-9 In Stock
  4. Then
  5. ACJEQM212 route product structure diagram
    ACJEQM2122102414-88-8
Inquiry

2. ACJEQM212 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDSFN864 route compound structure diagram
    ACDSFN864165528-85-8 In Stock
  2. Plus
  3. ACCSAO480 route compound structure diagram
    ACCSAO48021204-67-1 In Stock
  4. Then
  5. ACJEQM212 route product structure diagram
    ACJEQM2122102414-88-8
Inquiry

Comments (0)